Back to the list
Congress: ECR25
Poster Number: C-21337
Type: Poster: EPOS Radiologist (educational)
DOI: 10.26044/ecr2025/C-21337
Authorblock: R. E. Hinganitie, M. V. Dăbuleanu, A. M. Nechita, R. M. M. Proca, V. Ioana, D. Cuzino, A. V. Neagu; București/RO
Disclosures:
Roxana Elena Hinganitie: Nothing to disclose
Mirel Valentin Dăbuleanu: Nothing to disclose
Adina Maria Nechita: Nothing to disclose
Remus Marian Marian Proca: Nothing to disclose
Vasile Ioana: Nothing to disclose
Dragos Cuzino: Nothing to disclose
Andrei Valentin Neagu: Nothing to disclose
Keywords: Abdomen, Musculoskeletal soft tissue, Pancreas, CT, MR, Diagnostic procedure, Cancer, Metabolic disorders, Multidisciplinary cancer care
Learning objectives Define sarcopenia and its clinical implications in pancreatic disease. Explore imaging techniques for assessing muscle mass and quality. Highlight the prognostic value of sarcopenia in pancreatic cancer and chronic pancreatitis, emphasizing its role in management. Discuss future directions for sarcopenia assessment.
Read more Background Sarcopenia is a critical prognostic factor in pancreatic diseases, such as pancreatic cancer and chronic pancreatitis. This condition contributes to higher rates of treatment complications and reduced quality of life. Imaging techniques are vital for the early detection and monitoring of sarcopenia. This presentation reviews key imaging modalities used to assess sarcopenia in pancreatic disease, highlighting their clinical applications.
Read more Findings and procedure details 1. DefinitionIn 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) established a clinical definition of sarcopenia, characterizing it as a syndrome involving progressive and generalized loss of skeletal muscle mass and strength, associated with adverse outcomes. [1] Diagnosis requires the presence of both low muscle mass and low muscle function (strength or performance). [1] Recognizing advancements in the field, EWGSOP updated its definition in 2018 (EWGSOP2), emphasizing low muscle strength as the primary indicator of sarcopenia and...
Read more Conclusion Imaging-based assessment of sarcopenia is essential for developing personalized management strategies in pancreatic disease. By utilizing imaging techniques, healthcare providers can accurately evaluate muscle mass and quality, which are critical indicators of patient prognosis. As the understanding of sarcopenia's impact on treatment outcomes continues to evolve, establishing standardized protocols will be vital for improving patient care and optimizing therapeutic interventions in pancreatic diseases.
Read more References [1] Alfonso J. Cruz-Jentoft, Jean Pierre Baeyens, Jürgen M. Bauer, Yves Boirie, Tommy Cederholm, Francesco Landi, Finbarr C. Martin, Jean-Pierre Michel, Yves Rolland, Stéphane M. Schneider, Eva Topinková, Maurits Vandewoude, Mauro Zamboni, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age and Ageing, Volume 39, Issue 4, July 2010, Pages 412–423, https://doi.org/10.1093/ageing/afq034[2] Alfonso J Cruz-Jentoft, Gülistan Bahat, Jürgen Bauer, Yves Boirie, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves...
Read more
GALLERY